Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC

The identification of acquired resistance mutations has been essential in non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) active mutations. Rebiopsy plays a pivotal role in selecting the optimal treatment for patients who develop resistance to initial EGFR-ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Koyama, Kenichi, Miura, Satoru, Watanabe, Satoshi, Shoji, Satoshi, Koshio, Jun, Hayashi, Yoshiki, Ishikawa, Daisuke, Sato, Ko, Miyabayashi, Takao, Okajima, Masaaki, Ota, Takeshi, Tanaka, Tomohiro, Matsumoto, Naoya, Kuriyama, Hideyuki, Abe, Tetsuya, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Tanaka, Hiroshi, Kikuchi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013397/
https://www.ncbi.nlm.nih.gov/pubmed/35430596
http://dx.doi.org/10.1038/s41598-022-10288-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013397/
https://www.ncbi.nlm.nih.gov/pubmed/35430596
http://dx.doi.org/10.1038/s41598-022-10288-8

Ejemplares similares